(AUDIO) There are disparities in the sensitivities and specificities of glucose and lactose hydrogen breath tests used to diagnose small intestine bacterial overgrowth and to distinguish patients with irritable bowel syndrome from healthy individuals. Just how useful are these tests? Insights from an expert here.
Several classes of drugs seem to have positive effects for patients with GI disorders--including NSAIDs, anticonvulsants, alpha-adrenergic agents, neuromuscular agents, and antidepressants. Details here.
Probiotics, prebiotics, herbal preparations, and acupuncture are among the most popular options pursued for GI disorders. But how helpful are these nonmedical options?
(AUDIO) Here, Christina Surawicz, MD, describes an organized approach to the evaluation and management of patients with chronic diarrhea.
Here: an update on the challenges of detection, diagnosis, and management of celiac disease and non–celiac disease and the importance of gluten sensitivity.
(AUDIO) According to the Centers for Disease Control, more than one-third of US adults are obese. The CDC also estimates that as many as 1.4 million Americans suffer from inflammatory bowel disorder. So is there a link?
Are you making the most out of your patients’ office visits? If you are not listening effectively, the answer is no, said Douglas A. Drossman, MD, at the American College of Gastroenterology 77th Annual Scientific Meeting in Las Vegas.
The number of patients who are dying because of upper GI bleeding has decreased over the past 2 decades, according to a study reported at the American College of Gastroenterology 77th Annual Scientific Meeting.
Patients who have chronic constipation may be at increased risk for colorectal cancer and benign neoplasms, researchers reported at the American College of Gastroenterology 77th Annual Scientific Meeting. In addition, new colonoscopy surveillance guidelines have been issued.
(AUDIO) What is the natural history of systemic corticosteroid therapy in ulcerative colitis? Insights here from Dr Nabeel Khan, Assistant Professor of Medicine in Gastroenterology & Hepatology at Tulane Medical Center-author of a new study on this topic.